Company Comparison
Alnylam vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Alnylam | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Lagos, Nigeria |
| Founded | 2002 | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Alnylam
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Sector Overlap
Both Alnylam and 54gene operate in Biotech.
Browse all Biotech companies →